Novartis Canada applauds Canada's Drug Agency (CDA-AMC) for its positive draft recommendation to reimburse Kisqali® ...
Barca Blaugranes on MSN
Elche vs Barcelona, La Liga: Final score 1-3, Barça miss thousands of chances, cruise to comfortable win on the road
A big win on a very strange night ...
Highlights REAL’ aims to spark vital conversations about advanced prostate cancer and educate about the importance of treatment management WHIPPANY, N.J., January 29, 2026--(BUSINESS WIRE)--Today ...
Some heart issues can be asymptomatic. Unexplained and recent burping, especially after physical exertion, can indicate a ...
They can’t guarantee future health, but they can tell you the trajectory you’re on. By Dana G. Smith Take a minute to consider the last decade of your life. What type of physical shape do you hope to ...
ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. These highlights were written by the reporters and editors ...
Background: COVID-19 patients frequently present with abnormal liver function tests (LFTs) and elevated non-invasive liver fibrosis scores, such as the fibrosis-4 index (FIB-4), the non-alcoholic ...
Olivia Remes is a mental health and well-being researcher at the University of Cambridge, author of This Is How You Grow After Trauma and a life coach. Her research has covered everything from ...
Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...
As millions of Americans hit the road or took to the skies for the holidays, another seasonal traveler is picking up speed: influenza. The US Centers for Disease Control and Prevention estimates that ...
A Chicago dog under observation for biting an individual tested positive for rabies, the state’s first confirmed canine case in decades. According to the Illinois Department of Public Health, the dog ...
Shares of Altimmune rose on positive trial results for its treatment for metabolic dysfunction-associated steatohepatitis, or MASH, a liver disease. The stock climbed 7.5% to $5.43 in premarket ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results